GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human B-RAF bound to a dfg-out inhibitor 5B

Analyse Crystal structure of human B-RAF bound to a dfg-out inhibitor 5B in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4KSQ
Type
protein
Length
513 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase B-RAF
EC
2.7.11.1
UniProt
P15056
Ligands
1SW
Pockets
3 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase B-RAF (EC 2.7.11.1)protein25841% helix, 17% strandP15056
BSERINE/THREONINE-protein kinase B-RAF (EC 2.7.11.1)protein25542% helix, 17% strandP15056

Ligands and binding sites

  • 1SW · N-{7-cyano-6-[4-fluoro-3-({[3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-1,3-benzothiazol-2-yl}cyclopropanecarboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14470.750.8457empty
24380.740.83511SW
34110.690.81411SW

Interfaces

1 interface between chains.

  • A–B · 1137 Ų buried · 17 hydrogen bonds · protein-protein

Compared structures

  • 4KSQ · Crystal Structure of Human B-raf bound to a DFG-out Inhibitor 5B · the same entry in another collection · chain A against A, TM-score 1.00
  • P15056 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase B-RAF (P15056) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.